InsiderSource
MDLN

Medline Inc.

SEC CIK 2046386
$37.13 −17.0% · 90 days
90-day buys
$170.8K
1 open-market
90-day sells
$3.6B
12 open-market
Net insider flow
−$3.6B
Net selling
Filings shown
98
Most recent

At a glance

Over the last 90 days, insiders at MDLN have sold a net $3.6B of stock (1 open-market buy vs 12 sells).

Largest recent trade: Carlyle Group Inc. sold $1.07B of MDLN, trimming their stake 17%.

Most active filer: Bcp 8 Holdings Mozart Manager L.l.c., with 22 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for MDLN, newest first
View on SEC EDGAR ↗
MDLN
Medline Inc.
Buy CORCORAN JESSI L · Principal Accounting Officer · Open-market purchase · filed 3d ago ΔOwn NEW

Corcoran Jessi L, MDLN's Principal Account…, spent $170.8K of their own money on 5,000 shares at $34, opening a brand-new position.

+$170.8K
5,000 sh @ $34
MDLN
Medline Inc.
Sell BX Mozart ML-2 Holdco L.P. · 10% Owner · Open-market sale · filed 1w ago ΔOwn −18%

Bx Mozart Ml-2 Holdco L.p. sold $720.24M of MDLN, trimming their stake 18%.

−$720.24M
19.71M sh @ $37
MDLN
Medline Inc.
Sell BX Mozart ML-2 Holdco L.P. · 10% Owner · Open-market sale · filed 1w ago ΔOwn −100%

Bx Mozart Ml-2 Holdco L.p. sold $360.21M of MDLN, trimming their stake 100%.

−$360.21M
9.86M sh @ $37
MDLN
Medline Inc.
Sell BX Mozart ML-2 Holdco L.P. · 10% Owner · Open-market sale · filed 1w ago ΔOwn −18%

Bx Mozart Ml-2 Holdco L.p. sold $82.46M of MDLN, trimming their stake 18%.

−$82.46M
2.26M sh @ $37
MDLN
Medline Inc.
Sell BX Mozart ML-2 Holdco L.P. · 10% Owner · Open-market sale · filed 1w ago ΔOwn −100%

Bx Mozart Ml-2 Holdco L.p. sold $54.44M of MDLN, trimming their stake 100%.

−$54.44M
1.49M sh @ $37
MDLN
Medline Inc.
Sell Carlyle Group Inc. · 10% Owner · Open-market sale · filed Mar 12, 2026 ΔOwn −17%

Carlyle Group Inc. sold $1.07B of MDLN, trimming their stake 17%.

−$1.07B
26.11M sh @ $41
MDLN
Medline Inc.
Sell CP Circle ML Holdco GP, LLC · 10% Owner · Open-market sale · filed Mar 12, 2026 ΔOwn −17%

Cp Circle Ml Holdco Gp, Llc sold $1.07B of MDLN, trimming their stake 17%.

−$1.07B
26.11M sh @ $41
MDLN
Medline Inc.
Sell BCP 8 Holdings Mozart Manager L.L.C. · 10% Owner · Open-market sale · filed Mar 12, 2026 ΔOwn −13%

Bcp 8 Holdings Mozart Manager L.l.c. sold $667.53M of MDLN, trimming their stake 13%.

−$667.53M
16.48M sh @ $41
MDLN
Medline Inc.
Sell BCP 8 Holdings Mozart Manager L.L.C. · 10% Owner · Open-market sale · filed Mar 12, 2026 ΔOwn −100%

Bcp 8 Holdings Mozart Manager L.l.c. sold $333.86M of MDLN, trimming their stake 100%.

−$333.86M
8.24M sh @ $41
MDLN
Medline Inc.
Sell BCP 8 Holdings Mozart Manager L.L.C. · 10% Owner · Open-market sale · filed Mar 12, 2026 ΔOwn −13%

Bcp 8 Holdings Mozart Manager L.l.c. sold $76.42M of MDLN, trimming their stake 13%.

−$76.42M
1.89M sh @ $41
MDLN
Medline Inc.
Sell BCP 8 Holdings Mozart Manager L.L.C. · 10% Owner · Open-market sale · filed Mar 12, 2026 ΔOwn −100%

Bcp 8 Holdings Mozart Manager L.l.c. sold $50.45M of MDLN, trimming their stake 100%.

−$50.45M
1.25M sh @ $41
MDLN
Medline Inc.
Sell BX Mozart ML-2 Holdco L.P. · 10% Owner · Open-market sale · filed Mar 12, 2026 ΔOwn −13%

Bx Mozart Ml-2 Holdco L.p. sold $667.53M of MDLN, trimming their stake 13%.

−$667.53M
16.48M sh @ $41
MDLN
Medline Inc.
Sell BX Mozart ML-2 Holdco L.P. · 10% Owner · Open-market sale · filed Mar 12, 2026 ΔOwn −100%

Bx Mozart Ml-2 Holdco L.p. sold $333.86M of MDLN, trimming their stake 100%.

−$333.86M
8.24M sh @ $41
MDLN
Medline Inc.
Sell BX Mozart ML-2 Holdco L.P. · 10% Owner · Open-market sale · filed Mar 12, 2026 ΔOwn −13%

Bx Mozart Ml-2 Holdco L.p. sold $76.42M of MDLN, trimming their stake 13%.

−$76.42M
1.89M sh @ $41
MDLN
Medline Inc.
Sell BX Mozart ML-2 Holdco L.P. · 10% Owner · Open-market sale · filed Mar 12, 2026 ΔOwn −100%

Bx Mozart Ml-2 Holdco L.p. sold $50.45M of MDLN, trimming their stake 100%.

−$50.45M
1.25M sh @ $41

About MDLN insider activity

This page tracks every recent Form 4 filed for Medline Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is MDLN insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Medline Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.